Timely Ordering of Pharmacogenetic Testing
Doctors at The Hospital for Sick Children are studying if a special computer program, like a clever assistant, can help predict if a child will need certain medicines in the next three months. This program aims to identify which children might benefit from a genetic test called 'pharmacogenetic testing' *before* they start these specific medicines. The idea is that knowing how a child's body handles certain medicines based on their genes could help doctors choose the best medicine and dose for them. This study hopes to speed up this process, making sure children get the safest and most effective treatment right from the start.
At a glance
What is this study about?
Imagine your genes are like a secret instruction book inside your body. This book tells your body how to do all sorts of things, including how it might react to different medicines. For some medicines, knowing a bit about your 'instruction book' can help doctors pick the best one for you and get the dose just right. This is where 'pharmacogenetic testing' comes in – it's a special type of genetic test that looks at these particular instructions.
At The Hospital for Sick Children, researchers are looking at whether a smart computer program, sometimes called 'machine learning,' can help doctors decide if this genetic test would be useful for a child. This program is designed to predict if a child is likely to need certain specific medicines in the next three months. If the program suggests a child might need one of these medicines, doctors can then offer the pharmacogenetic test ahead of time.
The main goal of this study is to see if using this computer program means more children get this genetic test *before* they start these important medicines. It also wants to find out if having this information from the test actually helps doctors change which medicine they prescribe or what dose they give, leading to better and safer treatment for children.
Key takeaways
- This study uses a computer program to help identify children who might benefit from a genetic test.
- The genetic test helps doctors choose the best medicine and dose for certain treatments.
- It aims to make treatment more personal and potentially more effective for children.
- Participation involves considering a simple genetic test (like a blood test or cheek swab).
- It's about getting the right information to doctors *before* a child might need certain powerful medicines.
Who may be eligible?
This study is open to children who are staying as a patient at The Hospital for Sick Children. They need to be between 6 months and 18 years old.
However, some children won't be able to join. This includes children who have already had this type of genetic test before, or who have already taken one of the specific medicines mentioned in the study. Also, if a child is currently in the Intensive Care Unit (ICU) or is expected to leave the hospital very quickly on the same day they were admitted, they won't be able to take part.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Is your child currently staying at The Hospital for Sick Children?
- Is your child between 6 months and 18 years old?
- Has your child *not* had a pharmacogenetic test before?
- Has your child *not* taken medicines like azathioprine, warfarin, or phenytoin before?
- Is your child *not* currently in intensive care (ICU)?
- Is your child expected to stay in the hospital past the day of admission?
What does participation involve?
If your child is identified as potentially benefiting from this study, the research team or a specialised team focused on genetic testing for medicines will get in touch with their main care team. They will then discuss with you whether offering a pharmacogenetic test is suitable. Essentially, if you agree, your child would have a genetic test. This usually involves a simple blood test or a swab from inside the cheek to collect a DNA sample. The results of this test would then help your child's doctors make informed decisions about certain medications if they need them.
Potential risks and benefits
Locations (1)
- The Hospital for Sick ChildrenVerified postcodeToronto, Canada· Recruiting
Common questions
What is pharmacogenetic testing?
It's a special type of genetic test that looks at how your body handles certain medicines based on your genes, helping doctors choose the best treatment for you.
What does 'machine learning' mean in this study?
It's a clever computer program that learns from information to predict which children might benefit from the genetic test, acting like a smart assistant for doctors.
Will my child definitely get the genetic test if they join?
Not necessarily. The computer program identifies those who might benefit, and then your child's care team will discuss with you whether offering the test is appropriate.
What kind of medicines are 'targeted medications'?
These are specific medicines selected because genetic information can be very helpful in tailoring their use, such as azathioprine, warfarin, or phenytoin.
Who is paying for this study?
The information provided does not state who is funding the study, but the patient's care will not be affected regardless of participation.
How to find out more
Lillian Sung, MD, PhD
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.